Generative Artificial Intelligence in Pharmaceutical Formulation Development

Generative Artificial Intelligence (GenAI) has emerged as a transformative technology in pharmaceutical sciences, particularly in formulation development and personalized medicine. Traditional pharmaceutical formulation relies heavily on trial-and-error approaches, consuming substantial time, labor, and financial resources. Recent advances in machine learning, deep learning, large language models (LLMs), and generative neural networks have enabled predictive and data-driven formulation strategies. GenAI technologies can optimize excipient selection, predict physicochemical properties, enhance stability studies, simulate dissolution profiles, and accelerate dosage form design. Applications now extend to nanotechnology-based drug delivery systems, 3D printed medicines, personalized dosage forms, and intelligent process optimization. Despite significant progress, challenges such as limited datasets, regulatory uncertainty, explainability issues, ethical concerns, and data security remain barriers to widespread implementation. This review summarizes the principles of generative AI, its integration into pharmaceutical formulation development, recent advancements, industrial applications, limitations, regulatory considerations, and future opportunities. The review highlights the growing potential of GenAI to revolutionize pharmaceutical product development by reducing costs, accelerating timelines, and enabling precision medicine approaches.

Generative Artificial Intelligence, Pharmaceutical Formulation, Machine Learning, Personalized Medicine, Drug Delivery Systems, Large Language Models, AI in Pharmaceutics

1. Nithyanantham D, et al. Leveraging Artificial Intelligence for Advancements in Liquid Dosage Formulations in the Pharmaceutical Industry. Therapeutic Innovation & Regulatory Science. 2025. [Google Scholar] [Crossref]

2. Suksaeree J. A Review of Artificial Intelligence-Driven Smart and Sustainable Drug Delivery Systems. Sci. 2025. [Google Scholar] [Crossref]

3. Khater T, et al. Generative Artificial Intelligence Based Models Optimization Towards Molecule Design Enhancement. Journal of Cheminformatics. 2025. [Google Scholar] [Crossref]

4. Singh S, De A. The Paradigm Shift in Therapeutics: A Comprehensive Review of Artificial Intelligence in Drug Delivery Systems. RSC Pharmaceutics. 2026. [Google Scholar] [Crossref]

5. Pashikanti S, et al. AI-Powered Formulation Design: Neural Networks in Drug Development. Research Journal of Pharmaceutical Dosage Forms and Technology. 2025. [Google Scholar] [Crossref]

6. Kant S, et al. Artificial Intelligence in Drug Discovery and Development: Transforming Challenges into Opportunities. Discover Pharmaceutical Sciences. 2025. [Google Scholar] [Crossref]

7. Mane S, Bembde A. Generative Artificial Intelligence and Large Language Models in Pharmaceutical Formulation and Personalized Pharmacy. Drug Development and Industrial Pharmacy. 2026. [Google Scholar] [Crossref]

8. Lin L, et al. DeepSeek Powered Solid Dosage Formulation Design and Development. arXiv. 2025. [Google Scholar] [Crossref]

9. Okubena A, et al. FormuLLA: A Large Language Model Approach to Generating Novel 3D Printable Formulations. arXiv. 2026. [Google Scholar] [Crossref]

10. Shinde, Atharv, Hrushikesh Mhaismale, Pratik Pawar, Shriraj Mane, and Aditya Bembde. "Generative artificial intelligence and large language models in pharmaceutical formulation and personalized pharmacy: a review of opportunities, technical constraints, and regulatory readiness." Drug Development and Industrial Pharmacy 52, no. 5 (2026): 793-807. [Google Scholar] [Crossref]

11. Yadav, A. P., Singh, G., Singh, M. K., & Chaudhary, A. (2025). Artificial intelligence in optimizing formulations and excipients: Revolutionizing pharmaceutical product development. Journal of Advanced Scientific Research, 16(07), 9-18. [Google Scholar] [Crossref]

12. Warke, S., Katari, O., & Jain, S. (2026). Current Status on the Convergence of Artificial Intelligence and Formulation Development in Industry: A Review. Aaps Pharmscitech, 27(1), 44. [Google Scholar] [Crossref]

13. Dushyant, Narwal, S., Saini, V., Dhingra, A. K., Singh, J., Jasmeen, ... & Shabnam. (2026). Artificial Intelligence in Pharmaceutical Drug Development: Transforming Formulation and Innovation. Current Drug Discovery Technologies, 23(4), E15701638388052. [Google Scholar] [Crossref]

• The Role of Artificial Intelligence in Revolutionizing Library Services in Nairobi: Ethical Implications and Future Trends in User Interaction
• ESPYREAL: A Mobile Based Multi-Currency Identifier for Visually Impaired Individuals Using Convolutional Neural Network
• Comparative Analysis of AI-Driven IoT-Based Smart Agriculture Platforms with Blockchain-Enabled Marketplaces
• AI-Based Dish Recommender System for Reducing Fruit Waste through Spoilage Detection and Ripeness Assessment
• SEA-TALK: An AI-Powered Voice Translator and Southeast Asian Dialects Recognition